GSK ожидает одобрения нового препарата от рака лёгких — STAT News
GSK ожидает одобрения нового препарата от рака лёгких — STAT News UA.NEWS
GSK ожидает одобрения нового препарата от рака лёгких — STAT News UA.NEWS
ESMO26: The “paradigm-shifting” readouts in endometrial & ovarian cancer Clinical Trials Arena
РНЦРР проведет КИ CAR-T-препарата для лечения рака яичника Vademec.ru
Datroway Shows Encouraging Results for Triple-Negative Breast Cancer That Has Spread to the Brain news.cancerconnect.com
Больше не только Алматы: в Кыргызстане пытаются выстроить систему детской онкологии Правда.Ру
BioNTech, DualityBio say ADC had ‘modest’ benefit in breast cancer study BioPharma Dive
Black patients and people with a learning disability face longer waiting times at key stages of breast cancer care, according to a nationwide study led by the University of Surrey.
Nurse-Led Education Clears Up Clinical Trial Myths in Kidney Cancer Oncology Nursing News
ESMO ‘26: A cancer vaccine debate, Roche’s KRAS progress and Amgen’s ‘unprecedented’ data BioPharma Dive
Ivonescimab Plus Chemotherapy Improves Overall Survival in Advanced Biliary Tract Cancer - Summit Therapeutics Oncodaily
In a new paper published in Cell Reports Medicine, the UCL team outlines how they, in collaboration with a University of Cambridge team, developed a new type of treatment-predicting computer program that uses an individual's detailed genetic fingerprint to explore which treatments, if any, may kill their…
Искусственный интеллект научился лечить самую агрессивную форму рака груди RTVI
Seek Labs Expands Oncology Research for Sequence Ablation Therapeutics with Up to $3 Million in Foundation Support Yahoo Finance
Препарат Hansoh и GSK продлил жизнь пациентам с раком костей Investing.com